Niclas Stiernholm
Director/Board Member at Ontario Bioscience Industry Organization
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Douglas A. Hamilton | M | 57 |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | 6 years |
Rick Franklin | M | 78 |
Tarix Pharmaceuticals Ltd.
Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | 20 years |
Parimal Nathwani | M | - |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | - |
Maura Campbell | M | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 3 years |
Joerg Gruber | M | 63 |
Tarix Pharmaceuticals Ltd.
Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | 17 years |
Simon Goulet | M | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | - |
Jeremy K. Bridge-Cook | M | 55 |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 9 years |
Wendy Naimark | M | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 2 years |
Frank Florio | M | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 2 years |
Meenu Karson | F | 52 |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | - |
Shelley Boyd | F | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | - |
Michael Young | M | - |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | - |
Naheed Kurji | M | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 2 years |
Jung-Kay Chiu | M | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 11 years |
Cathy Szabo | F | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 9 years |
Kathleen Large | F | 64 | 5 years | |
James Graziadei | M | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 11 years |
Meenu Chhabra Karson | F | 51 |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | 4 years |
H. Norton | M | 63 |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | - |
Arun Menawat | M | 69 |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 11 years |
Richard John Meadows | M | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 11 years |
Anne Woods | F | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Allan | M | 82 | 3 years | |
Robert A. Uger | M | 53 | 8 years | |
Robert L. Kirkman | M | 75 | 8 years | |
Calvin Stiller | M | 83 | 8 years | |
James Parsons | M | 58 | 10 years | |
Thomas Reynolds | M | 65 | 7 years | |
Penka Petrova | M | 56 | 8 years | |
R. Dean Peterson | M | - | 4 years | |
Helena Tayton-Martin | M | 57 | 4 years | |
Luke Beshar | M | 65 | 7 years | |
Henry Friesen | M | 90 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | - |
Michael G. Moore | M | - | 7 years | |
James DeMesa | M | 66 | 9 years | |
Graham Strachan | M | 85 |
Allelix Biopharmaceuticals, Inc.
| 18 years |
Gilbert Wenzel | M | 67 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | - |
Peter G. Milner | M | 68 | - | |
Dan Stearne | M | - | 1 years | |
James Howard-Tripp | M | - |
Allelix Biopharmaceuticals, Inc.
| 2 years |
Eric Sievers | M | 60 | 3 years | |
Scott Duncan | M | - | - | |
Albert Agro | M | 59 | - | |
Beverly Incledon | M | - | - | |
Michael Cook | M | - | 1 years | |
Abdelmalik Slassi | M | 62 | 3 years | |
Yaping Shou | M | - | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 43 | 91.49% |
United States | 2 | 4.26% |
United Kingdom | 2 | 4.26% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Niclas Stiernholm
- Personal Network